FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia Par FDA – Press releases
FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List Par FDA – Press releases
EMA and European Association of Nuclear Medicine (EANM) bilateral meeting, Online, from 20 April 2026, 16:00 (CEST) to 20 April 2026, 17:20 (CEST) Par EMA – Events
FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S. Par FDA – Press releases
